CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Breast Cancer

ONCOLOGY. Vol. 24 No. 13
Pages: 1  2  
Next
REVIEW ARTICLE 

The Breast Health Global Initiative: Why It Matters to All of Us

By Benjamin O. Anderson, MD1 | December 16, 2010
1 Chair and Director, Breast Health Global Initiative, Fred Hutchinson Cancer Research Center,
Professor of Surgery and Global Health-Medicine, University of Washington, Seattle, Washington USA

ABSTRACT: The Breast Health Global Initiative (BHGI) applied an evidence-based consensus review process to the development of guidelines for breast cancer early detection, diagnosis, treatment and health care systems in low- and middle-income countries (LMCs). Breast cancer outcomes correlate with the degree to which (1) cancers are detected at early stages, (2) newly detected cancers can be diagnosed correctly, and (3) appropriately selected multimodality treatment can be provided properly and in a timely fashion. Cancer prevention through health behavior modification may influence breast cancer incidence in LMCs, although prevention strategies alone cannot eliminate the great majority of breast cancer cases. Diagnosing breast cancer at earlier stages will reduce breast cancer mortality, assuming that appropriate multimodality treatment is provided. Programs to promote breast self-awareness and clinical breast examination and resource-adapted mammographic screening are important steps in early detection. Obstacles to breast cancer early detection, diagnosis, and treatment occur in industrialized countries as well as LMCs. Understanding implementation in LMCs can inform policy makers in the U.S. on how to improve health care delivery in underserved communities, where the challenges mirror those of low-resource environments.

Introduction

ABSTRACT: The Breast Health Global Initiative (BHGI) applied an evidence-based consensus review process to the development of guidelines for breast cancer early detection, diagnosis, treatment and health care systems in low- and middle-income countries (LMCs). Breast cancer outcomes correlate with the degree to which (1) cancers are detected at early stages, (2) newly detected cancers can be diagnosed correctly, and (3) appropriately selected multimodality treatment can be provided properly and in a timely fashion. Cancer prevention through health behavior modification may influence breast cancer incidence in LMCs, although prevention strategies alone cannot eliminate the great majority of breast cancer cases. Diagnosing breast cancer at earlier stages will reduce breast cancer mortality, assuming that appropriate multimodality treatment is provided. Programs to promote breast self-awareness and clinical breast examination and resource-adapted mammographic screening are important steps in early detection. Obstacles to breast cancer early detection, diagnosis, and treatment occur in industrialized countries as well as LMCs. Understanding implementation in LMCs can inform policy makers in the U.S. on how to improve health care delivery in underserved communities, where the challenges mirror those of low-resource environments.

Introduction

Breast cancer is the most common cause of cancer-related death among women worldwide, with case fatality rates highest in low- and middle-income countries (LMCs). Globally, breast cancer is the most common female cancer, comprising 23% of all cancers that are newly diagnosed, in more than 1.1 million women each year.[1] More than 411,000 breast cancer deaths occur each year, accounting for more than 1.6% of female deaths from all causes.[2] The annual global burden of new breast cancer cases is projected to be 1.5 million this year, with an ever-increasing majority from LMCs.[3] Approximately 4.4 million women diagnosed with breast cancer in the last five years are currently alive, making breast cancer the single most prevalent cancer in the world.[1]

(MORE: Why My Neighbor’s Health Is Important to Me)

Evidence-based guidelines outlining optimal approaches to breast cancer detection, diagnosis, and treatment have been well-developed and disseminated in several high-resource countries.[6,7] However, these guidelines define optimal practice, and therefore have limited utility in LMCs. Optimal practice guidelines may be inappropriate for LMCs for numerous reasons, including inadequate personal resources, limited health care infrastructure, lack of pharmaceuticals, and cultural barriers. Hence, there is a need to develop clinical practice guidelines oriented specifically toward LMCs, and these guidelines need to take into consideration existing health care resources.

Cosponsored by the Fred Hutchinson Cancer Research Center and Susan G. Komen for the Cure, the Breast Health Global Initiative (BHGI) strives to develop evidence-based, economically feasible, and culturally appropriate guidelines that can be used in nations with limited health care resources, with the aim of improving breast cancer outcomes. The BHGI held three Global Summits to address specific topics as they relate to breast cancer in LMCs: health care disparities (Seattle, Washington, 2002);[8] evidence-based resource allocation (Bethesda, Maryland, 2005);[9] and guideline implementation (Budapest, Hungary, 2007).[10] Modeled after the approach of the National Comprehensive Cancer Network (NCCN), BHGI developed and applied a consensus panel process that is now formally endorsed by the Institute of Medicine (IOM) [11] to create resource-sensitive guidelines for breast cancer early detection,[12] diagnosis,[13] treatment [14] and health care systems [15] as related to breast health care in LMCs. These BHGI guidelines are intended to assist ministers of health, policymakers, administrators, and institutions in prioritizing resource allocation as breast cancer treatment programs are implemented and developed in their resource-constrained countries (Table 1).

Implementation research

The dominant paradigm in the medical community is that good research and publication should be sufficient to ensure the translation of scientific findings into general practice.[16] Unfortunately, a landmark IOM report from 2001 clearly identified the failure of much scientific innovation to be translated into practice.[17,18] More recently, Rubenstein and Pugh separated the IOM’s second translational block — clinical research to practice — into two parts: clinical research to guidelines, and guidelines to practice.[19] Implementation researchers maintain that the process is complex, and they have begun to identify factors and processes critical to the adoption of new technologies and practices.[20] Although there has already been some research assessing readiness for change, it has usually focused on just one component, such as providers or health units, or has focused on intention without considering self-efficacy or environment. As a conclusion in her extensive review of the implementation literature, Greenhalgh notes the need for more research on system readiness for innovation and for more studies evaluating implementation of specific interventions.[21]

TABLE 1
Consensus Guideline Publications of the Breast Health Global Initiative, 2002–2008

A review of available information strongly suggests that research could play a crucial role in applying the experience and knowledge of high-income societies to the challenges of women and breast cancer throughout the world. A recent survey of oncology experts from Latin American countries found that 94% of the surveyed experts consider clinical-epidemiologic research development on breast cancer insufficient in their country. The main reasons identified were insufficient funding and lack of available time.[22]

Very little research on guideline implementation has been done in LMCs. It is necessary to determine whether the basic frameworks and instruments described in high-income countries apply in these very different environments, and what adaptation is needed to make them both valid and feasible. A systematic program of research to develop appropriate readiness-assessment instruments and to identify effective implementation strategies is now needed in a variety of LMCs. As we move toward the adoption, implementation, and maintenance of the new evidence-based principles embodied in the BHGI guidelines, it is critical that careful evaluation is incorporated in the efforts, to ensure that lessons about effectiveness and efficiency are captured. It is precisely because resources are scarce in these countries that it is even more imperative that LMCs adopt effective practices as quickly as possible, and that implementation approaches are designed with limited resources in mind.[16]

Pages: 1  2  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by Iris Cooper | January 26, 2011 3:54 PM EST

Very interesting article. We can I hope look forward to improvements in care in the less wealthy countries as we all know that screening and treatment in early stage cancer is cheaper in the long run than having people presenting in the late stages or for palliation.

I do feel sorry for Mr Reiter as he seems to have had very bad experiences but that is not true of all of us. My daughter was diagnosed with breast cancer at 28yrs and pregnant. The care she had from surgeon's, obstetricians, chemotherapy and radiotherapy specialists, nurses and everyone else who assists in patient care, was second to none. She has since had a reconstruction which meant 11 hours in theatre and cancer (a different one) in the other breast.  Oh and she had the baby who is now nearly 5 yrs old and gorgeous like her mum.

Incidentially, I am a gynaecology oncology nurse at the Liverpool Women's Hospital in England. I see staff working together to improve the service given to patients every working day of my life. Looking after cancer patients is not an easy task and everyone who participates, whether in acute surgical or palliative care, in my hospital deserves a medal on every shift. I am not just talking about the surgeons either brilliant as they are, our domestic staff are all great and are essential in looking after the women. 

by alvin reiter | January 24, 2011 11:21 PM EST

you do a very valuable comment of newer aspects of breast cancer diagnosis and early treatment and question whether it is available to low income countries and individual.I know you have heard from me before but it is worth repeating.I  am a board certified head and neck and facial plastic surgeon for over 25 years in Beverly Hills California. My late wife Karen died prmaturely at the hands of the oncologist,breast and liver surgeons and the gross failure of the medical system in which human error,negligence and hubris can and did take a life.The facts are chilling and irrefutable.There are major lessons to be learned as well as a great read in my book "Even Doctors Cry".www.evendoctorscry.com.It is worth a look on the web site and a review by the Cancer Network.You can purchase it for $10.00 on Amazon.com.(I make about ten cents a book if that much)RSVP Alvin Reiter M.D. wojge@aol.com

This article reviewed

Research Training in Breast Cancer for Low and Middle Income Countries

International Disparity in Breast Cancer Outcomes: The Time to Close the Gap Is Now

Why My Neighbor’s Health Is Important to Me






 
RELATED CONTENT

Breast Cancer Screening, Risk, and Options for High-Risk Women
May 22, 2013
Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
May 20, 2013
50 Shades of Pink—And Why It Helps to Know the Difference
May 17, 2013
It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
ONCOLOGY,  May 13, 2013
HERA Trial: Invasive Lobular Breast Carcinoma Patients Derived Same Benefit From Trastuzumab Maintenance
May 7, 2013
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Preventing Exposure to Hazardous Drugs
  • Conflicts of Interest in Medicine: What About Ties to Payers?
  • Planning Treatment for Women With Recurrent Epithelial Ovarian Cancer
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
Click here to subscribe to our newsletter



CancerNetwork on Facebook
 
SearchMedica SEARCH RESULTS

Find peer-reviewed literature and websites for practicing medical professionals

CME on Breast Cancer
Evidence on Breast Cancer
Guidelines on Breast Cancer
Patient Education on Breast Cancer
Clinical Trials on Breast Cancer
Practical Articles on Breast Cancer
Research and Reviews on Breast Cancer
All "Breast Cancer" results

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy